Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe Cutaneous Adverse Reactions to Drugs in Latin America: The RACGRAD Study.
Rojas Mejía DV, Zwiener RD, Cardona Villa R, Ramírez LF, Silva Espinosa DL, Zanacchi VA, Piraino Sosa P, Ensina LF, Giavina Bianchi P, Coelho Portilho N, Vivolo Aún M, Matos Benavides E, Martínez Ruíz DM, Jares E, Serrano Reyes CD. Rojas Mejía DV, et al. Among authors: ensina lf. J Investig Allergol Clin Immunol. 2021 Jul 26;31(4):322-331. doi: 10.18176/jiaci.0497. Epub 2021 Feb 26. J Investig Allergol Clin Immunol. 2021. PMID: 32101172 Free article.
A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown-CSU study.
Türk M, Kocatürk E, Ertaş R, Ensina LF, Mariel Ferrucci S, Grattan C, Vestergaard C, Zuberbier T, Maurer M, Giménez-Arnau AM. Türk M, et al. Among authors: ensina lf. Clin Transl Allergy. 2024 Feb;14(2):e12343. doi: 10.1002/clt2.12343. Clin Transl Allergy. 2024. PMID: 38353300 Free PMC article.
Editorial: The complexity of urticaria.
Makris M, Altrichter S, Ensina LF, Kocatürk E, Rudenko M. Makris M, et al. Among authors: ensina lf. Front Allergy. 2023 Feb 17;4:1149540. doi: 10.3389/falgy.2023.1149540. eCollection 2023. Front Allergy. 2023. PMID: 36873049 Free PMC article. No abstract available.
CRUSE® -An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria.
Neisinger S, Sousa Pinto B, Ramanauskaite A, Bousquet J, Weller K, Metz M, Magerl M, Kocatürk E, Cherrez-Ojeda I, Gimenez-Arnau AM, Parisi CAS, Altrichter S, Ensina LF, Bouillet L, Asero R, Gonçalo M, Guillet C, Rutkowski K, Bernstein JA, Hardin H, Godse K, Brzoza Z, Sousa JIL, Thomsen SF, van Doorn M, Hide M, Ye YM, Vandersee S, Lapiņa L, Peter J, Zhao Z, Han L, Nasr I, Rockmann-Helmbach H, Sørensen JA, Kara RÖ, Kurjāne N, Kurchenko AI, Kaidashev I, Tsaryk V, Stepanenko R, Maurer M. Neisinger S, et al. Among authors: ensina lf. Clin Transl Allergy. 2024 Jan;14(1):e12328. doi: 10.1002/clt2.12328. Clin Transl Allergy. 2024. PMID: 38282190 Free PMC article.
Different phenotypes of drug-induced anaphylaxis-Data from the European Anaphylaxis Registry.
Hanschmann T, Francuzik W, Dölle-Bierke S, Hofmeier KS, Grabenhenrich L, Ruëff F, Renaudin JM, Pföhler C, Treudler R, Bilò MB, Lang R, Ensina LF, Christoff G, Cardona V, Wagner N, Reider N, Müller S, Dickel H, Worm M. Hanschmann T, et al. Among authors: ensina lf. Allergy. 2023 Jun;78(6):1615-1627. doi: 10.1111/all.15612. Epub 2022 Dec 20. Allergy. 2023. PMID: 36479710
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Among authors: ensina lf. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice.
Cherrez-Ojeda I, Bousquet J, Giménez-Arnau A, Godse K, Krasowska D, Bartosińska J, Szczepanik-Kułak P, Wawrzycki B, Kolkhir P, Allenova A, Allenova A, Tkachenko S, Teovska Mitrevska N, Mijakoski D, Stoleski S, Kolacinska-Flont M, Kuprys-Lipinska I, Molinska J, Kasperska-Zając A, Zajac M, Zamlynski M, Mihaltan F, Ulmeanu R, Zalewska-Janowska A, Tomaszewska K, Al-Ahmad M, Al-Nesf MA, Ibrahim T, Aqel S, Pesqué D, Rodríguez-González M, Wakida-Kuzunoki GH, Ramon G, Ramon G, Neisinger S, Bonnekoh H, Rukhadze M, Khoshkhui M, Fomina D, Larenas-Linnemann D, Košnik M, Oztas Kara R, Caballero López CG, Liu Q, Ivancevich JC, Ensina LF, Rosario N, Kvedariene V, Ben-Shoshan M, Criado RFJ, Bauer A, Cherrez A, Chong-Neto H, Rojo-Gutierrez MI, Rudenko M, Larco Sousa JI, Lesiak A, Matos E, Muñoz N, Tinoco I, Moreno J, Crespo Shijin C, Hinostroza Logroño R, Sagñay J, Faytong-Haro M, Robles-Velasco K, Zuberbier T, Maurer M. Cherrez-Ojeda I, et al. Among authors: ensina lf. J Allergy Clin Immunol Pract. 2024 Jun;12(6):1575-1583.e1. doi: 10.1016/j.jaip.2024.03.050. Epub 2024 Apr 9. J Allergy Clin Immunol Pract. 2024. PMID: 38604531 Free article.
91 results